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In the search for genes involved in type 1 diabetes (T1D), other than the well-established risk alleles at the human
leukocyte antigen loci, we have investigated the association and interaction of polymorphisms in genes involved in
the IL4/IL13 pathway in a sample of 90 Filipino patients with T1D and 94 controls. Ten single-nucleotide poly-
morphisms (SNPs), including two promoter SNPs in the IL4R locus on chromosome 16p11, one promoter SNP in
the IL4 locus on chromosome 5q31, and four SNPs—including two promoter SNPs—in the IL13 locus on chro-
mosome 5q31 were examined for association, linkage disequilibrium, and interaction. We found that both individual
SNPs (IL4R L389L; odds ratio [OR] 0.34; 95% confidence interval [CI] 0.17–0.67; ) and specific hap-Pp .001
lotypes both in IL4R (OR 0.10; 95% CI 0–0.5; ) and for the five linked IL4 and IL13 SNPs (OR 3.47;Pp .001
) were strongly associated with susceptibility to T1D. Since IL4 and IL13 both serve as ligands for aPp .004
receptor composed, in part, of the IL4R a chain, we looked for potential epistasis between polymorphisms in the
IL4R locus on chromosome 16p11 and the five SNPs in the IL4 and IL13 loci on chromosome 5q31 and found,
through use of a logistic-regression model, significant gene-gene interactions ( , corrected for multiplePp .045
comparisons by permutation analysis). Our data suggest that the risk for T1D is determined, in part, by poly-
morphisms within the IL4R locus, including promoter and coding-sequence variants, and by specific combinations
of genotypes at the IL4R and the IL4 and IL13 loci.
Introduction
Type 1 diabetes (T1D [MIM 222100]) is a multifactorial
autoimmune disease involving dysregulation of glucose
homeostasis that results from destruction of the insulin-
producing b cells within the pancreatic islets by auto-
reactive T cells (Tisch and McDevitt 1996; Azar et al.
1999). T1D, also known as “insulin-dependent diabetes
mellitus” or “juvenile-onset diabetes,” has an environ-
mental as well as a strong genetic component; the con-
cordance among MZ twins is 30%–70%, depending on
the human leukocyte antigen (HLA) type, and the sibling
risk ratio (ls) is 15 (Risch 1987; Pociot and McDermott
2002). A variety of genomewide scans in multiplex fam-
ilies have identified a number of linkage regions for T1D
(e.g., Cox et al. 2001), including the highly polymorphic
HLA region on chromosome 6p21, which has been es-
timated to contribute 150% of the total genetic risk
(Noble et al. 1996). Association studies in a number of
populations have demonstrated that, although HLA-
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DRB1, DQA1, and DQB1 are the major genetic deter-
minants of T1D susceptibility, multiple loci within the
HLA region appear to contribute to disease risk (Erlich
et al. 1996; Tisch and McDevitt 1996; Noble et al. 2000,
2002; Bugawan et al. 2002). Some HLA alleles and hap-
lotypes appear to confer susceptibility (positive asso-
ciation) and some protection (negative association),
whereas others are neutral. The identification of poten-
tially disease-related alleles and haplotypes has been
aided by the study of different human populations, with
differing patterns of linkage disequilibrium (LD). Link-
age and association studies outside the HLA region have,
thus far, with the exception of the insulin locus (Bennett
et al. 1996) and the CTLA-4 locus (Nistico et al. 1996;
Larsen et al. 1999; Lee et al. 2001; Klitz et al. 2002),
failed to identify individual genes and specific alleles that
are reproducibly associated with T1D.
Association studies with candidate genes involved in
immune responses, such as those encoding elements of
the T cell activation pathway, represent one approach
to finding T1D disease genes. IL4 and IL13 have been
shown to protect against diabetes development in ro-
dent models of T1D (Zaccone et al. 1999), suggesting
the possibility that cytokines involved in the Th1 and/
or Th2 pathways may play a role in T1D pathogenesis
(Glimcher and Murphy 2000). IL4 (MIM 147780) and
1506 Am. J. Hum. Genet. 72:1505–1514, 2003
IL13 (MIM 147683) are key components in the induc-
tion of the Th2 lymphocyte phenotype and the down-
regulation of the Th1 lymphocyte phenotype. In hu-
mans, IL4 transcript levels are greatly reduced in
new-onset T1D (Berman et al. 1996), and some authors
have speculated that IL13, as an anti-inflammatory cy-
tokine and a mediator of the Th2 pathway, represents
a potential therapeutic approach in the prevention of
T1D (Kretowski et al. 2000). The effects of IL4 and
IL13 on Th1/Th2 balance and on other immune phe-
notypes are mediated via binding to a receptor con-
taining the IL4R a chain. The heterodimeric receptor
consists of a high-affinity a subunit, encoded by the
IL4R locus (MIM 147781) on chromosome 16p11.2-
12.1, and either the common g subunit (IL2RG map-
ping to Xq13) or the IL13R a subunit (which maps to
chromosome X). The IL13 receptor, also a heterodimer,
is composed of one IL13R a subunit and either IL4R
or an IL13R a2 subunit. (Kawakami et al. 2001).
Some IL4R SNPs have been reported to affect signal
transduction via the IL4 receptor (Kruse et al. 1999)
and the level of gene expression of IL4R (Hackstein et
al. 2001). In addition, polymorphisms in the IL4R, IL4,
and the IL13 loci have been reported to be associated
with atopic asthma and serum immunoglobulin E (IgE)
levels (Noguchi et al. 1998; van der Pow Kraan et al.
1999; Graves et al. 2000; Sandford et al. 2000; Howard
et al. 2002). Thus, SNPs within the IL4R locus, as well
as those within the genes encoding the ligands IL4 and
IL13, represent a set of candidate gene polymorphisms
for T1D susceptibility, and we have examined associ-
ation and interaction of these SNPs in a Filipino
population.
Subjects and Methods
Subjects
All patients and controls were from the southern re-
gion of Luzon Island, Philippines. Patients included in
the study ( ) were affected by T1D as defined bynp 90
the 1997 American Diabetes Association classification
(Expert Committee on the Classification of Diabetes
Mellitus 1997). Patients were born in the Philippines,
and all have two Filipino parents. In a previous study,
these patients were characterized as having C-peptide
levels !0.3 mmol/liter and were tested for the presence
of antibodies to islet cell autoantigens, confirming that
they were indeed patients with classical T1D (Medici et
al. 1999). A total of 94 unaffected Filipino subjects with-
out a family history of diabetes were collected as the
control group.
Genotyping
Eight IL4R SNPs, two IL13 SNPs, and one IL4 SNP
were genotyped using a linear-array (immobilized probe)
method essentially as described by Mirel et al. (2002).
In brief, ∼100 ng of genomic DNA was PCR amplified
using nine biotinylated primer pairs in a single PCR. The
labeled amplicons were hybridized to an immobilized
sequence-specific oligonucleotide probe array on a nylon
membrane. The presence of bound amplicon to a specific
probe is detected using streptavidin–horseradish per-
oxidase and a soluble colorless substrate, 3,3′,5,5′-tetra-
methylbenzidine, which can be converted, in the pres-
ence of H2O2, to a blue precipitate. The two IL13 and
two IL4R promoter SNPs (table 1) were genotyped using
allele-specific PCR on a PE9700 thermal cycler (ABI),
measuring SyBr Green (Molecular Probes) fluorescence
(Higuchi et al. 1993).
Molecular Haplotyping
The seven-SNP haplotypes are labeled and identified
by the allele of IL4R SNPs 4–10 present on that hap-
lotype. Unambiguous haplotypes comprising seven IL4R
SNPs were obtained by inference when fewer than two
heterozygous SNPs were present in an individual. In
other cases, a molecular haplotyping method was used,
with details as follows: Two allele-specific PCRs were
performed in parallel, such that the amplification prod-
uct spanned two or more SNP loci. The choice of allele-
specific and common 5′-biotinylated primers depended
on which SNP loci were heterozygous but was limited
to the SNPs within IL4R exon 12. The two biotin-labeled
PCR products were subsequently hybridized separately
to the immobilized probe linear array described in the
“Genotyping” subsection, and the in-phase, linked SNP
alleles were identified.
Statistical Haplotype Estimation
Maximum-likelihood haplotype frequencies were com-
puted using an expectation-maximization (EM) algorithm
(see Excoffier and Slatkin 1995), as implemented by the
Arlequin software program (L. Excoffier).
Gene-Gene Interaction Modeling and Permutation
Analysis
Gene-gene interaction modeling.—Gene-by-gene in-
teractions at SNPs in different genes were evaluated by
assessing whether the genotype frequencies at unlinked
loci were independent (i.e., the IL13 and IL4 SNPs on
chromosome 5 and the IL4R SNPs on chromosome 16)
among patients. These analyses were performed for each
pair of unlinked SNPs, by means of a x2 test in contin-
gency tables with marginals defined by genotype counts
either in patients or in controls. The x2 values and the
corresponding degrees of freedom were added over all
IL4R SNP comparisons, and the P value of the sum of
x2 values was computed for each of the chromosome 5
SNPs.
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Table 1
SNPs Used in this Study, and Allele Frequencies in Patients with T1D and Controls
GENE
AND SNP
ALLELE
FREQUENCY IN
(%)
Pa ORb (95% CI)Reference Variant Controls Patients
IL4R:
5′ (3223) C T 41.9 51.1 .10 1.45 (.96–2.19)
5′ (1914) C T 44.1 42.7 .86 1.06 (.70–1.60)
I50V A G 44.1 53.9 .06 1.48 (.98–2.23)
N142N C G 1.1 0 .17 .52 (.00–2.13)
E375A A C 20.7 11.7 .02 .50 (.28–.90)
L389L G T 17.6 6.7 .001 .34 (.17–.67)
C406R T C 19.1 11.7 .05 .56 (.31–.99)
S478P T C 18.6 11.7 .06 .58 (.32–1.04)
Q551R A G 27.7 23.3 .34 .80 (.50–1.27)
S761P T C 100.0 100.0 … …
IL4:
5′ (524) T C 30.9 34.4 .46 1.18 (.76–1.82)
IL13:
5′ (1512) A C 30.6 41.0 .05 1.58 (1.03–2.42)
5′ (1112) C T 23.1 30.9 .12 1.49 (.94–2.37)
Intron 3 C T 40.4 45.6 .32 1.23 (.82–1.86)
R110Q G A 39.9 46.1 .23 1.29 (.85–1.95)
a Differences in reference allele frequencies between cases and controls were tested using
a x2 test. Values in boldface italic type are nominally significant P values ( ).P ! .05
b ORs refer to the variant allele. Where the frequency in patients was 0, the OR has
been computed under the assumption that a single patient sample carried the variant allele.
For each IL4R SNP, the homozygote genotype with
the highest odds ratio (OR) was given a value of 2, the
heterozygote was given a value of 1, the other homo-
zygote was 0. A logistic regression was performed on all
nine IL4R polymorphisms in this way, and a new nu-
merical variable, “il4r,” was derived as follows:
il4rp a G  a G  a G  a G1 3223 2 1914 3 50 4 142
a G  a G  a G  a G ,6 389 7 406 8 478 9 551
where Gi denotes the genotype (0, 1, or 2) at the ith
SNP position and aj denotes the coefficient fitted by
logistic regression (the coefficients fitted by the re-
gression were , , ,a p 0.368 a p 0.053 a p 0.371 2 3
, , , ,a p 0.061 a p 0.66 a p 1.08 a p 0.57 a p4 5 6 7 8
, and ). Epistasis was then tested in-0.54 a p 0.229
dependently for each of the five chromosome 5 SNPs
by fitting the following logistic regression mod-
el: , whereP(T1D) p exp (X)/[1  exp (X)] Xp C
, C is the intercept,b il4r b G  b (il4r#G )1 2 chr5i 3 chr5i
b represents the parameter estimates in the logistic
regression model, and Gchr5i is the genotype of one of
the chromosome 5 SNPs (values 0, 1, or 2).
Permutation analysis.—Since we compared five differ-
ent SNPs, it was important to correct for multiple tests.
However, a Bonferroni or a Dunn-Sidak correction is
not appropriate, since the IL4 and IL13 SNPs are not
independent (see table A1 in appendix A). Therefore,
permutation analysis was performed, keeping the patient
and control genotype frequencies constant but permut-
ing the chromosome 5 and chromosome 16 genotypes
within the patient and control groups separately. In this
way, only the epistatic interaction between the two ge-
netic regions was tested, and not the individual chro-
mosome 5 and chromosome 16 genetic associations.
Two hundred permutations were performed to test for
epistasis at all five chromosome 5 SNPs each time. Anal-
yses were performed using S-Plus, version 6.0 Profes-
sional (Insightful Corporation).
Results
We have performed an association and interaction anal-
ysis of three genes in the IL4/IL13 pathway in a case-
control study among Filipinos, including 10 SNPs in the
IL4R locus on chromosome 16p11, 2 of which are in
the promoter region. We also analyzed one SNP in the
IL4 promoter and four SNPs in the IL13 locus, two of
which are in the promoter region; these loci are closely
linked on chromosome 5q31.
Individual SNPs
The distributions of alleles at the individual SNPs in
the IL4R locus ( ), the IL4 locus ( ), and thenp 10 np 1
IL13 locus ( ) among patients and controls arenp 4
shown in table 1. LD patterns can be estimated using
maximum-likelihood approaches with individual geno-
type data from unrelated individuals (Slatkin and Ex-
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Table 2
Genotype Frequencies in Patients with T1D and Controls
SNP AND
GENOTYPE
FREQUENCY IN
(%)
FISHER’S
EXACT
TEST Pa OR (95% CI)Controls Patients
IL4R 3223:
CC 29.0 24.1 .78 (.40–1.51)
CT 58.1 51.7 .16 .77 (.43–1.38)
TT 12.9 24.1 2.15 (.99–4.68)
IL4R 1914:
CC 31.2 36.0 1.24 (.67–2.29)
CT 49.5 42.7 .66 .76 (.43–1.36)
TT 19.4 21.3 1.13 (.55–2.33)
IL4R 50:
AA 34.7 23.6 .58 (.30–1.11)
AG 43.2 44.9 .18 1.08 (.60–1.93)
GG 22.1 31.5 1.62 (.84–3.13)
IL4R 142:
CC 97.9 100.0
CG 2.1 0 .5
GG … …
IL4R 375:
AA 62.1 78.7 2.25 (1.17–4.33)
AC 34.7 19.1 .04 .44 (.23–.87)
CC 3.2 2.2 .70 (.12–4.32)
IL4R 389:
GG 67.4 87.6 3.43 (1.60–7.37)
GT 30.5 11.2 .002 .29 (.13–.63)
TT 2.1 1.1 .53 (.05–5.93)
IL4R 406:
CC 2.1 2.2 1.07 (.15–7.76)
CT 33.7 19.1 .06 .46 (.24–.92)
TT 64.2 78.7 2.05 (1.06–3.97)
IL4R 478:
CC 2.1 2.2 1.07 (.15–7.76)
CT 32.6 19.1 .09 .49 (.25–.96)
TT 65.3 78.7 1.96 (1.01–3.79)
IL4R 551:
AA 52.6 57.3 1.21 (.68–2.16)
AG 38.9 38.2 .56 .97 (.53–1.76)
GG 8.4 4.5 .51 (.15–1.76)
IL4 590:
CC 10.5 12.4 1.20 (.48–2.98)
CT 40.0 42.7 .81 1.12 (.62–2.01)
TT 49.5 44.9 .83 (.47–1.49)
IL13 intron 3:
CC 33.7 31.5 .90 (.49–1.68)
CT 50.5 46.1 .54 .84 (.47–1.49)
TT 15.8 22.5 1.55 (.74–3.25)
IL13 110:
AA 12.6 27.0 2.55 (1.19–5.49)
AG 54.7 38.2 .02 .51 (.28–.92)
GG 32.6 34.8 1.10 (.60–2.03)
IL13 1512:
AA 48.4 34.8 .57 (.31–1.03)
AC 41.9 48.3 .14 1.29 (.72–2.32)
CC 9.7 16.9 1.89 (.78–4.57)
IL13 1112:
CC 60.2 51.7 .71 (.39–1.27)
CT 33.3 34.8 .24 1.07 (.58–1.97)
TT 6.5 13.5 2.26 (.81–6.31)
a Values in boldface italic type are nominally significant P values
( ).P ! .05
Table 3
Molecular IL4R Haplotypes (Complex Alleles) in Filipino Patients
with T1D and Controls
SEVEN-SNP
HAPLOTYPE
FREQUENCY IN
x2 Pa ORb (95% CI)
Controls
( )cNp 188
Patients
( )cNp 178
CAGTTAT 70.7 77.0 .49 1.38 (.9–2.2)
CCTCCGT 15.4 6.7 .005 .4 (.2–.8)
GAGTTAT 1.1 0 .50 .51 (.0–5.8)
CAGTTGT 7.4 11.2 .23 1.57 (.8–3.2)
CCGCCGT 3.2 5.1 .38 1.62 (.6–4.6)
CCTTTGT 1.6 0 .27 .35 (.0–3.5)
CCTGTAT .5 0 .98 1.12 (.0–15.8)
Total (6 df) .08
a The value in boldface italic type is a nominally significant P value
( ).P ! .05
b Where the frequency in patients was 0, the ORs have been com-
puted under the assumption that a single patient sample carried the
haplotype.
c Sample size (N) refers to the number of chromosomes.
coffier 1996.) The patterns of pairwise LD for these
SNPs inferred among the control population are shown
in tables A1 and A2 in appendix A. Among the indi-
vidual IL4R SNPs, three (E375A, L389L, and C406R)
showed a nominally significant association (variant allele
decreased) with T1D. The variant allele at I50V was
slightly increased, whereas, at S478P, the variant allele
was decreased in patients; both associations had a P
value of .06. The two promoter SNPs were not signifi-
cantly associated with T1D, although the variant allele
of the3223 SNP was slightly increased among patients
(OR 1.45, ). With the exception of this promoterPp .10
SNP and the I50V SNP, with which it is in strong LD,
the variant allele at each SNP is underrepresented among
patients. Some of the polymorphic amino acid residues
in this chain appear to be biologically important and
affect IL-4 receptor signaling (Kruse et al. 1999). Of the
10 IL4R SNPs typed in this study, the L389L SNP, how-
ever, showed the strongest association with T1D in this
population, with significantly lower frequencies among
patients than controls (OR 0.34; ). Since thisPp .001
is a silent (synonymous) polymorphism, it is unlikely that
this SNP is responsible for the observed protective effect
for T1D. We note that this SNP is in very strong LD
(table A1 in appendix A) with the nonsynonymous flank-
ing SNPs (E375A, C406R, S478P, and Q551R) and that
these SNPs all show a trend toward protection (negative
association). The L389L SNP is also in strong negative
LD with the 3223 promoter SNP. We also note that
the LD pattern between the variant allele at I50V and
the other coding-sequence SNPs differ between Filipinos
(table A1 in appendix A) and whites (Mirel et al. 2002).
In the comparison of genotypes at the individual IL4R
SNPs (table 2), the protective effect appears to be dom-
inant, in that the heterozygote for IL4R L389L has an
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Table 4
Estimated Haplotype Frequencies in Patients with T1D and Controls, for 10-SNP IL4R Haplotypes,
Based on EM Algorithm Analysis of the Seven-SNP Molecular Haplotype (Table 3) and the Three
Additional 5′ SNPs
HAPLOTYPE
LABELa
IL4R 10-SNP
HAPLOTYPEb
FREQUENCY IN % (SD)c IN
ORd (95% CI) PeControls ( )fNp 188 Patients ( )fNp 180
CC(H-5) CC-ACCTCCGT 5.8 (1.7) 0 .09 (.0–.5) .001
CT(H-5) CT-ACCTCCGT 8.5 (2.3) 5.8 (2.2) .66 (.3–1.6) .33
CT(H-3) CT-GCCTCCGT .9 (.6) 0 .62 (.0–6.0) .21
TC(H-3) TC-GCCTCCGT 0 .9 (1.1) 1.70 .19
NOTE.—Total x2 (23 df) for all 10-SNP haplotypes p 36.03; .Pp .04
a The haplotype label names the 10-SNP haplotypes by the identity of the 3223 and 1914 alleles,
followed, in parentheses, by the eight-SNP haplotype ID as presented by Mirel et al. (2002).
b The hyphen in each haplotype separates the two promoter SNPs from the eight coding-sequence SNPs.
c The SD was computed using 100 bootstrap replicates. Of the possible 512 haplotypes, 24 were observed.
d Where the frequency in patients was 0, the ORs have been computed under the assumption that a
single patient sample carried the haplotype. Where the frequency in controls was 0, the ORs have been
computed under the assumption that a single control sample carried the haplotype.
e Differences in allele frequencies between cases and controls were tested using a x2 test.
f Sample size (N) refers to the number of chromosomes.
Table 5
Estimated IL4 and IL13 Haplotype Frequencies in Patients
with T1D and Controls, for Five SNPs on Chromosome
5q31
FIVE-SNP
HAPLOTYPEa
FREQUENCY IN %
(SD)b IN
ORc P
Controls
( )Np 188
Patients
( )dNp 176
CACCA 4.1 (1.3) 3.5 (1.7) .84
CACCG 8.9 (2.2) 10.6 (2.9) 1.21
CACTA 1.3 (1.1) 3.0 (1.8) 2.26
CCCCG 1.5 (1.0) .9 (.9) .61
CCTCG 1.1 (.9) 5.5 (2.3) 5.19 .02
CCTTA 12.6 (2.4) 9.3 (2.0) .71
TACCG 33.6 (3.8) 21.9 (3.9) .55 .03
TACTA 16.4 (3.3) 16.3 (3.0) .99
TACTG 5.0 (1.7) 3.2 (1.4) .62
TCCCG 4.6 (1.8) 9.8 (2.9) 2.23 .06
TCCTA 1.3 (1.1) 0 .42
TCTCG 5.3 (2.4) 1.7 (1.2) .31 .07
TCTTA 4.1 (2.1) 12.8 (2.2) 3.47 .004
Others 0 1.7
Total (12 df) .001
a In the table and text, the haplotypes are designated with
the SNPs in the following order: IL4 524, IL13 1512,
IL131112, IL13 intron 3, and IL13 110. The physical order
of the SNPs on 5q31 is IL131512, IL131112, IL13 intron
3, IL13 110, IL4 524. Of the 17 inferred five-SNP haplo-
types, only those with an estimated frequency of 11% are
shown.
b The SD was computed using 100 bootstrap replicates.
c Where the frequency in patients was 0, the ORs have
been computed under the assumption that a single patient
sample carried the haplotype.
d N is reduced because of missing genotypes.
OR of 0.29. Among the individual SNPs on chromosome
5q31, only the variant alleles at the two IL13 promoter
SNPs were increased among patients (OR 1.58, Pp
for1512; and OR 1.49, for1112) (table.05 Pp .12
1). When genotype frequencies are compared, however,
the IL13 R110Q SNP showed a nominally significant
association in this population ( ; table 2) ThesePp .03
data suggest that the variant homozygote, but not the
heterozygote, may be at increased risk for T1D. Given
the multiple comparisons and the relatively small sample
size in this study, however, this association with the IL13
R110Q SNP should be seen as a hypothesis-generating
observation that requires further testing in other studies.
Haplotypes
IL4R.—IL4R haplotypes (complex alleles) were esti-
mated using an EM method (Excoffier and Slatkin 1995)
and were directly determined by molecular haplotyping
methods. The molecular haplotyping method allowed
the unambiguous assignment of phase for the six SNPs
in exon 12. With the addition of inferred phase for
N142N, seven different seven-SNP IL4R haplotypes
were determined in this population, and their frequencies
among patients and controls were compared (table 3).
We focused initially on the seven-SNP haplotypes in our
analysis, to allow comparison with the results of Mirel
et al. (2002), our earlier study of a sample of white
patients with T1D in which the two promoter SNPs of
IL4R were not typed. One specific seven-SNP haplotype
(CCTCCGT) was significantly underrepresented among
Filipino patients (OR 0.4; ). This same haplo-Pp .005
type was found to be protective (significant negative as-
sociation) by the TDT method in the Human Biological
Data Interchange (HBDI), a repository of multiplex white
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Table 6
Test for Independence Between
Genotype Frequencies at IL4R SNPs
and Genotype Frequencies at Five
Chromosome 5 SNPs
SNP
P FOR
Controls Patientsa
IL4 524 .15 .001
IL13 1512 .77 .78
IL13 1112 .93 .73
IL13 110 .99 .91
IL13 intron3 .99 .02
a Values in boldface italic type are
nominally significant P values (P !
)..05
Table 7
Epistasis between IL4R and Five Chromosome 5 SNPs
SNP b3 SE OR
Wald’s
x2
Nominal
P Valuea
IL4 524:il4r .22 .10 .81 4.55 .03
IL13 1512:il4r .04 .15 1.04 .06 .81
IL13 1112:il4r .10 .16 1.10 .37 .55
IL13 intron3:il4r .17 .09 1.18 3.19 .07
IL13 110:il4r .14 .09 1.15 2.24 .14
NOTE.—The overall P value for all five tests by permutation
analysis was (see text).P ! .045
a The value in boldface italic type is a nominally significant
P value ( ).P ! .05
families with T1D (Mirel et al. 2002). In the HBDI fam-
ilies, stratification based on the highest-risk HLA geno-
type (HLA-DRB1*0301-DQB1*0201/HLA-DRB1*04-
DQB1*0302) was necessary to demonstrate the protective
effect of the IL4R haplotype (Mirel et al. 2002). A sig-
nificant negative association was found only among those
families in which neither affected sib was DR3/4, pre-
sumably because the effect of the IL4R polymorphisms
was relatively modest compared with the risk conferred
by this high-risk HLA genotype (conferring a disease risk
higher than in DR3/3 or DR4/4 homozygotes). Among
Filipinos, a significant protective effect of a specific IL4R
haplotype was observed without such HLA stratification
(table 3). This may reflect the absence, among Filipinos,
of a higher risk associated with DR3/4 than with DR3/3
or DR4/4 genotypes (Bugawan et al. 2002). We have at-
tributed the lack of the “DR3/4 effect” among Filipinos,
well established by many studies of T1D in whites, to the
differing patterns of LD of DQB1 alleles with DRB1*04
alleles between Asians and whites (Bugawan et al. 2002).
The molecular haplotyping approach used here did not
allow the assignment of phase for the two promoter SNPs
and the I50V SNP in the IL4R locus. Consequently, we
used the EM approach to estimate frequencies for 10-
SNP haplotypes, using these three individual SNPs and
the seven-SNP haplotype previously determined by mo-
lecular methods (table 4). Of the 17 10-SNP haplotypes
with an estimated frequency 11% in either group, only
one 10-SNP haplotype containing the protective seven-
SNP haplotype—CCA-CCTCCGT, labeled “CC(H-5)” in
table 4—appeared strongly negatively associated (OR
0.10; 95% CI 0–0.5; ) with disease. Interest-Pp .001
ingly, the other haplotype (CTA-CCTCCGT, labeled
“CT[H-5]” in table 4), which contained the same seven-
SNP haplotype and which differs only at the1914 SNP,
was not significantly associated with disease (OR 0.66;
). Our data suggest that a specific combinationPp .33
of IL4R promoter SNPs with a particular coding-sequence
allelic variant contributes to the risk for T1D.
IL4 and IL13.—The IL4 and the four IL13 SNPs are
in strong LD (appendix A). We estimated five-SNP hap-
lotype frequencies and compared them between patients
and controls (table 5); the overall distributions were dif-
ferent ( ), and one haplotype, TCTTA, wasPp .005
strongly associated with T1D (OR 3.47; ). OnePp .004
surprising observation is that the four-SNP IL13 hap-
lotype CTTA appears to be associated with disease only
in combination with the T allele at the IL4 524 pro-
moter SNP, since the CCTTA haplotype shows no dis-
ease association. These data could reflect LD between
the associated five-SNP haplotype and some nearby
causal gene or that a particular combination of a pro-
moter variant at IL4 and promoter and coding variants
at IL13 are responsible for an elevated T1D risk (gene-
gene interaction).
Gene-Gene Interaction
Since IL4 and IL13 both serve as ligands for a receptor
composed, in part, of the IL4R a chain, we looked
for potential gene-gene interactions between polymor-
phisms in the IL4R locus on chromosome 16p11 and
the five SNPs in the IL4 and IL13 loci on chromosome
5q31. In one approach, we examined the statistical in-
dependence for genotypes at the 10 IL4R SNPs and the
genotypes at each of the IL4 and IL13 SNPs (table 6).
No deviation from independence was found for these
SNPs among controls, but a significant deviation was
found for the IL4 524 promoter SNP ( ) andPp .001
the IL13 intron 3 SNP ( ) among patients.Pp .019
To assess whether the IL4 or the IL13 SNPs modified
the effect on T1D susceptibility due to IL4R SNPs, we
modeled epistasis through use of a logistic-regression
model. For each of the five chromosome 5q31 SNPs, we
tested whether the effect of the combined IL4R SNP
genotypes on T1D susceptibility differed depending on
the chromosome 5q31 SNP genotype. The results (table
7) indicate that there is an epistatic interaction between
the IL4R genotypes and IL4 and IL13 genotypes. To
address the issue of multiple comparisons, we performed
permutation analysis. In 22/200 permutations, one or
more of the five SNP tests showed a ; in 13/P ! .035
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200, one or more of the SNP tests had a , andP ! .035
another one had a ; and, in 9/200, one had aP ! .075
, another a , and a third a .P ! .035 P ! .075 P ! .135
Thus, the pattern observed in table 7 has a probability
of . We conclude that the epistatic interactionP ! .045
observed between these chromosome 5 SNPs and the
IL4R genotypes is statistically significant and indicates
that, in this data set, the genotypes in the IL4-IL13 re-
gion affect the genetic susceptibility to T1D conferred
by IL4R.
To illustrate this interaction, we also calculated the
ORs for individual IL4R SNPs as a function of the IL4
and IL13 SNP genotype and plotted them in the same
format used by Howard et al. (2002) to exemplify IL4R-
IL13 epistasis with regard to susceptibility to asthma.
The ORs and P values from the stratified contingency-
table analyses are shown in figure 1. The differences
among the ORs were greatest for the IL4R 3223 SNP
and the four IL13 SNPs. For example, the IL13 1512
SNP AA genotype has an OR of 3.21 (95% CI 0.84–
12.23) with the TT IL4R 3223 genotype and an OR
of 0.53 (95% CI 0.29–0.98) with the CC genotype (fig.
1C), whereas the IL13 1112 SNP AA genotype has an
OR of 2.67 (95% CI 1.01–7.05) with the TT IL4R
3223 genotype and an OR of 0.62 (95% CI 0.36–1.06)
with the CC genotype (fig. 1D).
Discussion
We have investigated the association and interaction of
polymorphisms in three candidate genes (IL4R, IL4, and
IL13) in a sample of unrelated Filipino patients with
T1D and control individuals. Of the 10 individual IL4R
SNPs examined in this study, the strongest association
was with L389L (OR 0.34; ), although thePp .001
flanking SNPs, which show LD to it and to each other,
are also associated. Analysis of IL4R SNP haplotypes or
complex alleles suggested that one haplotype appeared
to confer dominant protection. Initially, we focused on
seven-SNP haplotypes, determined by a molecular
method, to allow comparison with the results of Mirel
et al. (2002). The same seven-SNP haplotype was as-
sociated negatively with T1D among Filipinos as in
white multiplex families (Mirel et al. 2002). In general,
the interpretation of disease association studies with
multiple candidate SNPs is complicated by the issue of
multiple testing and the consequent reduction in statis-
tical power. In the case of this seven-SNP IL4R haplo-
type, we have observed a similar protective effect in two
different populations and in two different study de-
signs—namely, case-control and TDT. In addition to the
biological plausibility (e.g., the expected functional con-
sequences) of these SNPs, these observations strongly
suggest that variants of the IL4R molecule influence sus-
ceptibility to T1D. In this study, we also examined two
promoter SNPs, allowing estimation of 10-SNP haplo-
types for IL4R. The analysis of 10-SNP IL4R haplotypes
among Filipinos suggests that a specific promoter variant
in combination with specific coding sequence variants
may be responsible for the observed protection (table
4).
The observation of an interaction between polymor-
phisms in the IL13 and IL4 genes and polymorphism
in the gene (IL4R) encoding the receptor for the prod-
ucts of these two represents an interesting and biolog-
ically plausible hypothesis that, given the multiple com-
parisons, requires further testing. Another example of
epistasis was reported in a recently published study of
patients with asthma that showed a gene-gene inter-
action between IL4R and IL13 in the determination of
serum IgE levels (Howard et al. 2002.).
Several recent studies have shown that the reference
(wild-type) allele at several of the IL4R SNPs examined
here is associated with atopic asthma and increased IgE
levels (Sandford et al. 2000; Howard et al. 2002). Thus,
it appears that the same alleles at IL4R SNPs confer an
increased risk for a canonical Th1 (T1D) and Th2
(atopic asthma) disease. If true, these associations argue
against an effect on Th1/Th2 balance mediated by poly-
morphism in the IL4R gene and suggest instead that
these variations may influence some aspect of immune
regulation and homeostasis in both Th1 and Th2 path-
ways and possibly B cell activation, as well. Conceiv-
ably, the observed patterns of disease association reflect
the effect of IL4R polymorphisms on the balance be-
tween the activation of Th1 and Th2 cells and that of
T regulatory cells. Finally, the extent of risk for T1D
may be determined by specific combinations of variants
at the IL4R locus and at the genes encoding its two
ligands, IL4 and IL13.
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Appendix A
Table A1
Pairwise LD between SNPs in this Cohort (IL4R SNPs)
LD
3223 (T) 1914 (T) 50 (G) 142 (G) 375 (C) 389 (T) 406 (C) 478 (C) 551 (G)
3223 (T) … .183*** .176*** .004 .063*** .068*** .061*** .059*** .068***
1914 (T) 1.0 … .068*** .005 .105 .029* .014 .011 .027
50 (G) .75 .81 … .006 .049** .067*** .043** .039** .079***
142 (G) 1.0 1.0 1.0 … .002 .002 .002 .002 .003
375 (C) .70 .70 .53 1.0 … .139*** .152*** .147*** .145***
389 (T) .93 .29 .86 1.0 1.0 … .126*** .122*** .122***
406 (C) .74 .13 .49 1.0 1.0 .89 … .150*** .133***
478 (C) .74 .62 .48 1.0 1.0 .85 1.0 … .135***
551 (G) .56 .17 .65 1.0 .96 .96 .96 1.0 …
NOTE.—Upper right triangle: D. Lower left triangle: D′ (normalized LD, ). All values refer to the variant allele indicated′D p D/Dmax
in the table. Statistically significant LD values are indicated as follows: * ; ** ; *** .P ! .05 P ! .01 P ! .0001
Table A2
Pairwise LD between SNPs in this Cohort (IL4 and IL13 SNPs)
LD
IL4 524 (C) IL13 1512 (C) IL13 1112 (T) IL13 intron3 (T) IL13 110 (A)
IL4 524 (C) … .062*** .069*** .024 .063***
IL13 –1512 (C) .29 … .163*** .057*** .058**
IL13 –1112 (T) .41 1.0 … .077*** .078***
IL13 intron 3 (T) .13 .31 .54 … .201***
IL13 110 (A ) .34 .31 .55 .84 …
NOTE.—Upper right triangle: D. Lower left triangle: D′ (normalized LD, ). All values refer to the′D p D/Dmax
variant allele indicated in the table. Statistically significant LD values are indicated as follows: * ; **P ! .05 P !
; *** ..01 P ! .0001
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